Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 6, 2003, Pages 743-748

  Easey, A J ^b   Wallace, G M F ^c   Hughes, J M B ^b   Jackson, J E ^b   Taylor, W J ^d   Shovlin, C L ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR MALFORMATION; FAMILY STUDY; FEMALE; GENETIC DISORDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STROKE; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0038016648     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.6.743     Document Type: Article

References (27)

1. Bideau A, Brunet G, Heyer E, et al. An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a geneological and demographic study. Ann Hum Biol 1992;19:233-47.
2. Kjeldsen AD, Vase P, Green A, Hereditary hemorrhagic telangiectasia (HHT): a population-based study of prevalence and mortality in Danish HHT patients. J Intern Med 1999;245:31-9.
3. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary haemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002;19:140-148.
4. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66-7.
5. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
6. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-29.
7. Haitjerna T, Disch F, Overtoom TIC, et al. Screening family members of patients with hereditary haemorrhagic telangiectasia. Am J Med 1995;99:519-24.
8. Kjeldsen AD, Oxhøj H, Andersen PE, et al. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999;116:432-9.
9. Fulbright RK, Chaloupka JC, Putman CM, et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998;19:477-84.
10. Graf CJ, Perrett GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983;58:331-7.
11. Perret G, Nishioka H. Arteriovenous malformations: an analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the cooperative study. In: Sahs A, et al. eds. Intracranial aneurysms and subarachnoid haemorrhage: a cooperative study. Philadelphia: JB Lippincott, 1969:200-22.
12. Crawford PM, West CR, Chadwick DW, et al. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986;49:1-10.
13. Brown RD, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial malformations. J Neurosurg 1988;68:352-7.
14. Itoyama Y, Uemura S, Ushio Y, et al. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg 1989;71:805-9.
15. Ondra SL, Troupp H, George ED, et al. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurgery 1991;73:387-91.
16. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Proiect 1981-1986. Methodology, demography and incident cases of first ever stroke. J Neurol Nurosurg Psychiatry 1988;51:1373-80.
17. Bonita R, Beaglehole R, North JDK, Event, incidence and case-fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol 1984;120:236-43.
18. Daly LE, Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998;147:783-90.
19. Breslow NE, Day NE. Statistical methods in cancer research - the analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1980;1:124-46, 169-82, 192-246.
20. Willemse RB, Mager JJ, Westermann CJJ, et al. Bleeding risk of cerebrovascular malformations in hereditary haemorrhagic telangiectasia. J Neurosurg 2000;92:779-84.
21. Maher CO, Piepgras DG, Brown RD, et al. Cerebrovascular manifestations in 321 cases of hereditary haemorrhagic telangiectasia. Stroke 2001;32:877-82.
22. Gupta P, Mordin C, Curtiss J, et al. PAVMs: effect of embolisation on right-to-left shunt, hypoxaemia and exercise tolerance in 66 patients. Am J Roentgenol 2002;179:347-55.
23. Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg 1998;88:641-6.
24. Fleetwood IG, Steinberg GK, Arteriovenous malformations. Lancet 2002;359:863-73.
25. Maraire JN, Awad IA. Intracranial cavernous malformations: lesion behaviour and management strategies. Neurosurgery 1995;37:591-605.
26. Henkes H, Nasher H-C, Berg-Dammer E, et al. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 1998;20:479-92.
27. Fisher WS, Decision analysis: A tool of the future: an application to unruptured arteriovenous malformations. Neurosurgery 1989;24:129-35.